Cargando…
Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile?
Adjuvant endocrine therapy improves recurrence and survival rates, but has side effects and is inconvenient. The aim of this study was to determine the preferences of premenopausal women who had adjuvant endocrine therapy in a randomised trial. In all, 85 (or eighty-five) women completed semistructu...
Autores principales: | Duric, V M, Fallowfield, L J, Saunders, C, Houghton, J, Coates, A S, Stockler, M R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361537/ https://www.ncbi.nlm.nih.gov/pubmed/16333242 http://dx.doi.org/10.1038/sj.bjc.6602874 |
Ejemplares similares
-
Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?
por: Jansen, S J T, et al.
Publicado: (2001) -
What Survival Benefits are Needed to Make Adjuvant Sorafenib Worthwhile After Resection of Intermediate- or High-Risk Renal Cell Carcinoma? Clinical Investigators’ Preferences in the SORCE Trial
por: Lawrence, Nicola J., et al.
Publicado: (2018) -
Multidisciplinary brain metastasis clinic: is it effective and worthwhile?
por: Rajpurohit, Annu, et al.
Publicado: (2020) -
Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
por: Ribi, K, et al.
Publicado: (2012) -
Travel Less. Make It Worthwhile.
por: Geitmann, Anja
Publicado: (2020)